Here's what traders are watching as we get closer to the first presidential debate on Monday. » Read More
By: Jake Novak
Renewed voter anger over greedy CEOs means the first candidate to promise to send a big exec jail would surge in the polls, says Jake Novak. » Read More
By: Jake Novak
As you watch the first debate on Monday night, keep an eye out for the "fake excuse." CNBC senior columnist Jake Novak explains. » Read More
It's been nothing short of awful this year for IPOs, but some are hopeful that the fall will see a flurry of activity.
The euro/yen chart has multiple features which suggest a downside target near 107.
It's not just greed that makes companies like Mylan charge outrageous prices for drugs, explains former FDA official Scott Gottlieb.
Driving as we know it is about to fundamentally change, says VC Venky Ganesan. Here's what the future will look like in a world of self-driving cars.
Experts say U.S. travelers are suffering from a vacation deficit, and Labor Day weekend may be the perfect opportunity to remedy that.
Neither Trump nor Clinton are really connecting with female voters. You know what they need to do? Watch the hit movie "Bad Moms," says Jake Novak.
Mylan says the health-care system is to blame for families having to pay more for life-saving drugs like EpiPen and Joe Minarik says, sadly, that’s pretty much true.
Yellen and Fischer's comments at Jackson Hole leave markets right where they started the session.
Does your office have a serious case of the summer Fridays...every day? Here are four tips to juice productivity.
Mylan is trying to win over critics by issuing coupons to help consumers pay for its high-priced EpiPen. Don't be fooled, says Vox writer Sarah Kliff.
Tough talk on the campaign trail aside, scrapping NAFTA is not going to happen, says UBS's Jorge Mariscal. Here's why.
Donald Trump's pivot to Mr. Nice Guy must've completely freaked out Hillary Clinton, says Jake Novak—enough so that she felt the need to remind the world of all the bad things he's said!
The FDA and Congress enabled Mylan to secure a monopoly on EpiPens and then jack up the prices, says this intellectual-property expert. So why can't they just end it?
Janet Yellen's Jackson Hole speech won't provide the answers, says Marc Bushallow. Here's what will get the economy moving again.
Call it crowd-sourcing for algorithmic trading.
Best Buy reported better-than-expected numbers and the stock spiked. Here are four reasons to get out now, says wealth manager Michael Yoshikami.
Get the best of CNBC in your inbox